Widefield OCT angiography
Posted inInteresting Papers

Widefield OCT angiography

Widefield OCTA Quiz

Widefield OCTA Board-Style Quiz

Select a single best answer per question. Correct answers highlight in green, wrong answers in red. A green explanation box appears after you select.

Tip: You can reset to practice again. Good luck!

1. Introduction

  • Optical Coherence Tomography Angiography (OCTA)
  • Non-invasive, volumetric, high-resolution vascular imaging modality.
  • Provides 3D reconstructions of retinal and choroidal vasculature.
  • Advantages over dye-based angiography
  • No exogenous contrast agents → avoids risks (e.g., anaphylaxis).
  • Better resolution for microvascular detail.
  • Volumetric vs. 2D imaging.
  • Lower cost, easier procedure.
  • Limitations of conventional OCTA
  • Small field of view → misses peripheral pathology (e.g., ischemia).
  • Peripheral ischemia is a critical biomarker in disease progression.

Clinical Pearls

  • OCTA is safer and more detailed than dye-based angiography.
  • Peripheral ischemia is often missed with conventional OCTA but is crucial in diabetic retinopathy and vein occlusions.

Exam Tips

  • OCTA uses motion contrast (erythrocyte movement) as its endogenous contrast agent.
  • Dye angiography uses exogenous contrast (fluorescein or indocyanine green).

2. Technical Concerns for Extending the Field of View

2.1 Primer

  • Two approaches:
  • Montage imaging: multiple small images stitched together.
  • Single-shot imaging: widefield captured in one volume.
  • Montage = impractical clinically (time-consuming).
  • Single-shot = relies on swept-source OCT (SS-OCT), high-speed lasers, motion correction.

Clinical Pearls

  • Single-shot imaging is more practical for clinical use.
  • Eye motion tracking is essential for reliable OCTA.

Exam Tips

  • Swept-source OCT is the backbone of widefield OCTA.

2.2 Defining “Widefield”

  • No consensus in literature.
  • Metrics:
  • Lateral dimensions (mm).
  • Eye angle (center of eye).
  • Visual angle (nodal point).
  • Definitions:
  • Widefield: Eye angle 75°, Visual angle 50°.
  • Ultra-widefield: Eye angle 146°, Visual angle 100°.
  • Anatomical definition:
  • Widefield = posterior pole + mid-periphery.
  • Ultra-widefield = extends to far periphery.

Clinical Pearls

  • Widefield OCTA captures macula + mid-periphery → better disease monitoring.
  • Ultra-widefield OCTA is needed for far peripheral pathology (e.g., retinopathy of prematurity).

Exam Tips

  • Widefield ≈ 50° visual angle; Ultra-widefield ≈ 100°.
  • Eye angle vs. visual angle distinction is exam-relevant.

2.3 Improving Scan Acquisition Rate

  • Limitation: motion artifacts if acquisition too slow.
  • Innovations:
  • Fourier Domain Mode-Locking (FDML) lasers.
  • Vertical Cavity Surface Emitting Laser (VCSEL) systems.
  • Stretched-Pulse Mode-Locking (SPML) sources.
  • Sampling in k-space → requires resampling for uniformity.
  • Scanning systems:
  • Galvanometer scanners (GS) → limited by inertia.
  • Bidirectional interleaved scanning improves efficiency.
  • Trade-off: undersampling reduces resolution but acceptable for ischemia detection.

Clinical Pearls

  • Faster acquisition = less motion artifact, larger field of view.
  • Undersampling acceptable for ischemia detection but not for microaneurysms.

Exam Tips

  • FDML and VCSEL are key enabling technologies.
  • Nyquist limit defines minimum sampling density.

2.4 Optical Considerations

  • Widefield requires complex optics:
  • 4f lens systems → expand scanning angle.
  • Optical relay → reduce vignetting.
  • Challenges:
  • Vignetting (beam blocked by pupil/misalignment).
  • Signal attenuation (floaters, fluid, defocus).
  • Solutions:
  • Mydriasis, optical relay alignment.
  • Algorithms to correct attenuation.

Clinical Pearls

  • Vignetting is more problematic in widefield imaging.
  • Signal attenuation can mimic pathology → must be corrected.

Exam Tips

  • 4f lens system expands scanning angle.
  • Vignetting is a common artifact in widefield OCTA.

2.5 OCTA Data Processing

  • OCTA = interferometric imaging (amplitude + phase).
  • Processing approaches:
  • Phase-based → sensitive to noise, requires compensation.
  • Amplitude-based → more robust, no phase correction needed.
  • Advanced algorithms:
  • Phase-Stabilized Complex-Decorrelation (PSCD) → real-time widefield imaging.

Clinical Pearls

  • Amplitude-based processing is more clinically robust.
  • Real-time display ensures quality control during acquisition.

Exam Tips

  • First OCTA images were phase-based.
  • PSCD algorithm = modern standard for widefield OCTA.

Clinical Pearls

  • Widefield OCTA is especially valuable in diseases with peripheral involvement.
  • Enables simultaneous macular + peripheral pathology detection.

Exam Tips

  • OCTA > fundus photography for microvascular detail.
  • Widefield OCTA = better for ischemia mapping than conventional OCTA.

🩺 Clinical Utility of Widefield OCTA

3.1 Diabetic Retinopathy (DR)

  • Pathophysiology
  • Microvascular damage → capillary dropout, ischemia, neovascularization.
  • Peripheral ischemia strongly correlates with disease progression and risk of proliferative DR.
  • Widefield OCTA role
  • Detects peripheral non‑perfusion areas missed by conventional OCTA.
  • Identifies microaneurysms, intraretinal microvascular abnormalities (IRMAs), and neovascularization.
  • Quantifies ischemic burden → guides anti‑VEGF or laser therapy.
  • Clinical impact
  • Better than fundus photography for microvascular detail.
  • Can monitor treatment response longitudinally.

Clinical Pearls

  • Peripheral ischemia is a stronger predictor of progression than central changes.
  • Widefield OCTA can detect early neovascularization before clinical exam.

Exam Tips

  • OCTA shows non‑perfusion as dark areas (loss of flow signal).
  • IRMAs vs. neovascularization: IRMAs remain intraretinal; neovascularization breaches into vitreous.

3.2 Retinal Vein Occlusion (RVO)

  • Pathophysiology
  • Venous obstruction → ischemia, edema, neovascularization.
  • Peripheral ischemia drives neovascular complications.
  • Widefield OCTA role
  • Maps ischemic zones beyond posterior pole.
  • Detects collateral vessel formation and capillary dropout.
  • Monitors anti‑VEGF treatment response.
  • Clinical impact
  • Identifies patients at risk for neovascular glaucoma.
  • Guides laser photocoagulation to ischemic periphery.

Clinical Pearls

  • Widefield OCTA is superior to fluorescein angiography for ischemia mapping without dye risks.
  • Collateral vessels appear as tortuous channels bridging occluded segments.

Exam Tips

  • Central RVO vs. branch RVO: widefield OCTA helps differentiate ischemic burden.
  • Neovascularization of disc or elsewhere = high‑risk feature → exam favorite.

3.3 Retinopathy of Prematurity (ROP)

  • Pathophysiology
  • Abnormal vascular development in premature infants.
  • Peripheral avascular retina → neovascularization.
  • Widefield OCTA role
  • Non‑invasive imaging in infants (no dye injection).
  • Detects avascular zones and neovascular tufts.
  • Quantifies vascular tortuosity and dilation.
  • Clinical impact
  • Early detection of plus disease.
  • Guides timing of laser or anti‑VEGF therapy.

Clinical Pearls

  • Widefield OCTA is safer than fluorescein angiography in neonates.
  • Plus disease = vascular dilation + tortuosity → exam buzzword.

Exam Tips

  • Widefield OCTA can visualize avascular retina beyond posterior pole.
  • Remember: ROP staging depends on location (zones) and severity (stages).

3.4 Uveitis

  • Pathophysiology
  • Inflammation → vascular leakage, ischemia, neovascularization.
  • Widefield OCTA role
  • Detects peripheral ischemia and capillary dropout.
  • Identifies choroidal neovascularization in posterior uveitis.
  • Clinical impact
  • Helps differentiate inflammatory vs. ischemic changes.
  • Monitors treatment response to steroids or immunosuppressants.

Clinical Pearls

  • OCTA avoids dye leakage artifacts → clearer vascular detail in uveitis.
  • Peripheral ischemia can mimic vasculitis → widefield OCTA clarifies.

Exam Tips

  • OCTA shows flow voids in ischemic retina.
  • Dye angiography shows leakage; OCTA shows flow only.

3.5 Inherited Retinal Dystrophies

  • Pathophysiology
  • Genetic disorders → progressive photoreceptor and vascular degeneration.
  • Widefield OCTA role
  • Detects peripheral vascular dropout.
  • Monitors progression of choriocapillaris loss.
  • Clinical impact
  • Research tool for understanding disease mechanisms.
  • May guide gene therapy trials.

Clinical Pearls

  • OCTA reveals vascular changes earlier than fundus exam.
  • Useful in Stargardt disease, retinitis pigmentosa, cone‑rod dystrophies.

Exam Tips

  • OCTA shows choriocapillaris flow deficits in inherited dystrophies.
  • Remember: dystrophies often start peripherally → widefield imaging critical.

3.6 Age‑Related Macular Degeneration (AMD)

  • Pathophysiology
  • Choroidal neovascularization in neovascular AMD.
  • Widefield OCTA role
  • Detects peripheral vascular changes beyond macula.
  • Monitors anti‑VEGF therapy response.
  • Clinical impact
  • Identifies subclinical CNV.
  • May predict progression to advanced AMD.

Clinical Pearls

  • OCTA can detect CNV before leakage appears on fluorescein angiography.
  • Widefield imaging shows peripheral vascular changes linked to progression.

Exam Tips

  • OCTA CNV = tangled vascular networks.
  • Dry AMD shows choriocapillaris flow deficits.

📝 Board‑Exam Key Takeaways

  • Diabetic Retinopathy → peripheral ischemia predicts progression.
  • Retinal Vein Occlusion → ischemia mapping guides laser therapy.
  • Retinopathy of Prematurity → avascular retina + plus disease detection.
  • Uveitis → OCTA avoids dye leakage artifacts.
  • Inherited Dystrophies → peripheral vascular dropout precedes photoreceptor loss.
  • AMD → OCTA detects CNV earlier than dye angiography.